Anatomical Resection in Colorectal Liver Metastases Patients
- Conditions
- The Characteristics of CRLM Patients Who Would Benefit More From Anatomical Resection
- Interventions
- Procedure: Anatomical Resection
- Registration Number
- NCT05673564
- Lead Sponsor
- Fudan University
- Brief Summary
The type of liver resection (anatomical resection, AR or nonanatomical resection, NAR) for colorectal liver metastases (CRLM) is subject to debate. The debate may persist because some certain prognostic factors, associated with aggressive biological behavior of tumor, have been overlooked. The aim of our study was to investigate the characteristics of patients who would benefit more from anatomical resection for colorectal liver metastases.
- Detailed Description
729 patients who underwent hepatic resection of CRLM were retrospectively collected from June 2012and May 2019. Treatment effects between AR and NAR were compared in full subgroup analyses. Tumor relapse-free survival (RFS) was evaluated by a stratified log-rank test and summarized with the use of Kaplan-Meier and Cox proportional hazards methods.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 729
(1)Age 18-79 years;(2) Histologically proven colorectal adenocarcinoma;
(1) the histologic type of tumor was not called adenocarcinoma; (2) peritoneal metastasis; (3) number of liver metastasis >3; (4) simultaneous anatomical and nonanatomical resections; (5) R2 resection; (6) history of previous hepatectomy; (7) incomplete data. The rest of patients were divided into 2 groups: patients undergoing an AR, and patients undergoing a NAR.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description anatomical resection group Anatomical Resection Anatomical resection was defined as resection of 1 or more complete hepatic segments in our study, including bisegmentectomy, right hemihepatectomy, left hemihepatectomy, extended right hemihepatectomy, extended left hemihepatectomy, single segmentectomy, caudate lobectomy, or a combination of these.
- Primary Outcome Measures
Name Time Method RFS 2012.6.1-2022.6.1 Relapse-free survival since patients undergoing hepatic resection
- Secondary Outcome Measures
Name Time Method OS 2012.6.1-2022.6.1 Overall survival since patients undergoing hepatic resection